Get exclusive member benefits & effect social change. Join Today
Krabbe disease is a rare and usually deadly disorder of the nervous system. It is an inherited genetic disease, which means that it is passed down in families. People with Krabbe disease are not able to create enough of a substance called galactosylceramidase, which is needed to make myelin. Myelin is a material your body uses to surround and protect nerve fibers. Without this protection, cells in the brain will die, and the nerves in the brain and other parts of the body will not work properly.
Krabbe disease is seen mostly in infants (onset by age 6 months), but it can also develop later in life. Unfortunately, there is currently no cure for Krabbe disease, and most infants with this disease will die before age 2.
In general, the younger the age of onset of Krabbe disease, the faster the disease will progress. People who develop Krabbe disease later in life may have less severe symptoms than infants who get the disease.
Symptoms of early-onset Krabbe disease include:
Symptoms of late-onset Krabbe disease in older children and adolescents include:
Krabbe disease is a genetic disorder, which means that a person inherits the disease from their parents. It is caused by a genetic mutation — a permanent change in the DNA sequence that makes up a certain gene. The mutation affects the message that the gene sends to the cells in your body.
The gene for Krabbe disease can be found on chromosome 14. A child needs to get an abnormal gene from both parents to inherit the disease. The abnormal gene results in a shortage of an important enzyme that your body needs called galactosylceramidase (GALC).
Your body needs GALC to make and maintain myelin, a substance that surrounds and helps protect your nerves. In people with Krabbe disease, who do not have GALC, a substance called galactolipids will build up in the brain. Galactolipids are stored by cells called globoid cells. For this reason, Krabbe disease is sometimes also called globoid cell leukodystrophy. There are two types of Krabbe disease:
Krabbe disease is very rare. According to the Mayo Clinic, the disease affects about 1 in every 100,000 people in the United States. It occurs most frequently in people of Scandinavian descent. A child has a one in four chance of developing the disorder if both parents have the defective gene.
Your doctor will conduct a physical exam to look for symptoms. The doctor will take a sample of blood or skin tissue biopsy, and send it to a laboratory for analysis. The laboratory can test for GALC enzyme activity in the sample. If GALC activity levels are very low, the child may have Krabbe disease. The following tests may also be performed to confirm a diagnosis:
There is no cure for Krabbe disease. However, the following treatments may be given to patients to help alleviate their symptoms:
Research has found two procedures that may have an effect on the progression of Krabbe disease, rather than just treating the symptoms: bone marrow transplantation (also called hematopoietic stem cell transplantation) and cord blood transplantation. During these procedures, a person with Krabbe disease receives cells from a healthy person. The new cells are able to make the GALC enzyme that the patient could not make on his or her own. Both of these procedures have risks of their own.
An adult will donate some bone marrow (a material found in bones) to replace the bone marrow in the child who has Krabbe disease. The best results have been only in patients with late-onset Krabbe disease who have been treated before severe symptoms develop. It has not been helpful in infants with early-onset Krabbe disease who have already developed symptoms.
A doctor will transfuse cord blood stem cells into the patient. The cells are obtained from the umbilical cord of a donor who is not related to the patient. However, this procedure has also been shown to help only those patients treated before symptoms appear.
The disease is usually life threatening. Since it damages a person’s central nervous system, complications include:
The outlook is very poor. On average, infants who develop Krabbe disease will die before age 2. Children who develop the disease later in life will live a bit longer, but typically die between 2 and 7 years after they are diagnosed.
If both parents carry the genetic defect that causes Krabbe disease, there is a 25 percent chance of passing the disease to their child. The 25 percent risk of passing on the disease cannot be lowered if parents both carry the genetic mutation. The only way to avoid the risk is if the carriers decide to not have children. The parents can, however, find out if they carry the gene for Krabbe disease through a blood test. If there is a family history of Krabbe disease, prenatal tests can be done to screen the fetus for the condition. Genetic counseling is recommended for people with a family history of Krabbe disease if they are considering having children.
Written by: Jacquelyn Cafasso
Medically reviewed on: Jan 20, 2016: Steve Kim, MD
Enter your symptoms in our Symptom Checker to find out possible causes of your symptoms. Go.
Enter any list of prescription drugs and see how they interact with each other and with other substances. Go.
Enter its color and shape information, and this tool helps you identify it. Go.
Find information on drug interactions, side effects, and more. Go.